Table 2.

Summary of studies on EUS chemoablation of pancreatic cystic lesions

Reference	n	Ablative agent	Complete resolution (n)	Partial resolution (n)	Complications
Oh 2008	14	Ethanol lavage with paclitaxel injection	11	2	7% abdominal pain 43% hyperamylasemia 7% pancreatitis
Oh 2009	10	Ethanol lavage with paclitaxel injection	6	2	10% pancreatitis
Oh 2011	52	Ethanol lavage with paclitaxel injection	29	6	2% fever 2% pancreatitis 2% abdominal pain 2% splenic vein obstruction
DeWitt 2014	22	Ethanol lavage with paclitaxel injection	10	5	13% abdominal pain 10% pancreatitis 3% peritonitis 3% gastric wall cyst
Moyer 2016	10 (alcohol arm 4; alcohol-free arm 6)	Saline or ethanol lavage followed by paclitaxel and gemcitabine injection	67% in saline arm versus 75% in ethanol arm	-	Ethanol arm: 20% pancreatitis Saline arm: None reported
Kim 2017	36 (ethanol ablation 8; ethanol lavage with paclitaxel ablation 28)	Ethanol ablation or ethanol lavage followed by paclitaxel injection	19	7	7% abdominal pain 7% pancreatitis 2% intracystic hemorrhage
Choi 2017	164	Ethanol lavage with paclitaxel injection	114	31	4% pancreatitis 1% psuedocyst 1% abscesses, 0% (1/164) risk of portal vein thrombosis, fever, splenic vein obstruction, pancreatic duct stricture Pericystic spillage, intracystic hemorrhage